Literature DB >> 26628044

[Non-withdrawal-related delirium : Evidence on prevention and therapy].

R Haussmann1, M Bauer2, M Donix2.   

Abstract

Delirium is a severe and common yet under-diagnosed disorder in the clinical routine. Multiple factors may contribute to the development of delirium, which is associated with increased mortality and high healthcare costs. Treatment of delirium is often provided with delay and limited to pharmacological interventions. This article summarizes the key symptoms for delirium as well as risk factors and highlights the pharmacological and non-pharmacological options for treatment and prevention.

Entities:  

Keywords:  Antipsychotic drugs; Delirium prevention; Delirium therapy; Non-pharmacological interventions; Pathophysiology

Mesh:

Substances:

Year:  2016        PMID: 26628044     DOI: 10.1007/s00115-015-0027-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  53 in total

Review 1.  Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine.

Authors:  P T Trzepacz
Journal:  Semin Clin Neuropsychiatry       Date:  2000-04

Review 2.  Delirium in elderly people.

Authors:  Sharon K Inouye; Rudi G J Westendorp; Jane S Saczynski
Journal:  Lancet       Date:  2013-08-28       Impact factor: 79.321

3.  The role of antipsychotics in treating delirium.

Authors:  Larry Tune
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

4.  Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial.

Authors:  Tareef Al-Aama; Christopher Brymer; Iris Gutmanis; Sarah M Woolmore-Goodwin; Jacquelin Esbaugh; Monidipa Dasgupta
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-15       Impact factor: 3.485

5.  Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis.

Authors:  Joost Witlox; Lisa S M Eurelings; Jos F M de Jonghe; Kees J Kalisvaart; Piet Eikelenboom; Willem A van Gool
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

6.  Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.

Authors:  Kotaro Hatta; Yasuhiro Kishi; Ken Wada; Takashi Takeuchi; Toshinari Odawara; Chie Usui; Hiroyuki Nakamura
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

Review 7.  Reflex control of immunity.

Authors:  Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

Review 8.  [Delirium in patients with neurological diseases: diagnosis, management and prognosis].

Authors:  K Hüfner; B Sperner-Unterweger
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

9.  Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery.

Authors:  U Prakanrattana; S Prapaitrakool
Journal:  Anaesth Intensive Care       Date:  2007-10       Impact factor: 1.669

10.  A randomized controlled trial of quetiapine versus placebo in the treatment of delirium.

Authors:  Tayyeb A Tahir; Eamonn Eeles; Venugopal Karapareddy; Prem Muthuvelu; Sian Chapple; Bethan Phillips; Toyin Adyemo; Daniel Farewell; Jonathan I Bisson
Journal:  J Psychosom Res       Date:  2010-06-23       Impact factor: 3.006

View more
  3 in total

Review 1.  [Treatment with psychotropic agents in patients with dementia and delirium : Gap between guideline recommendations and treatment practice].

Authors:  Walter Hewer; Christine Thomas
Journal:  Z Gerontol Geriatr       Date:  2017-01-25       Impact factor: 1.281

Review 2.  [Delirium in the context of intensive care medicine-Part 1: epidemiology, definitions, pathophysiology].

Authors:  R Haußmann; A Postler; M Mirus
Journal:  Nervenarzt       Date:  2022-10-21       Impact factor: 1.297

Review 3.  [Delirium in the context of intensive care medicine-Part 2: diagnosis, prevention and treatment].

Authors:  R Haußmann; A Postler; M Mirus
Journal:  Nervenarzt       Date:  2022-10-21       Impact factor: 1.297

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.